Free Trial

BIOLASE (BIOL) Competitors

BIOLASE logo
$0.01 +0.00 (+13.21%)
As of 06/30/2025

BIOL vs. AVGR, NUWE, NAYA, DYNT, CUTR, SONX, STSS, HSDT, IONM, and AFIB

Should you be buying BIOLASE stock or one of its competitors? The main competitors of BIOLASE include Avinger (AVGR), Nuwellis (NUWE), NAYA Biosciences (NAYA), Dynatronics (DYNT), Cutera (CUTR), Sonendo (SONX), Sharps Technology (STSS), Helius Medical Technologies (HSDT), Assure (IONM), and Acutus Medical (AFIB). These companies are all part of the "medical equipment" industry.

BIOLASE vs. Its Competitors

Avinger (NASDAQ:AVGR) and BIOLASE (NASDAQ:BIOL) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their media sentiment, risk, profitability, earnings, dividends, analyst recommendations, valuation and institutional ownership.

Avinger has a net margin of 0.00% compared to BIOLASE's net margin of -41.65%. Avinger's return on equity of 0.00% beat BIOLASE's return on equity.

Company Net Margins Return on Equity Return on Assets
AvingerN/A N/A N/A
BIOLASE -41.65%-1,782.73%-55.31%

BIOLASE has a consensus price target of $1.20, indicating a potential upside of 9,900.00%. Given BIOLASE's stronger consensus rating and higher probable upside, analysts clearly believe BIOLASE is more favorable than Avinger.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Avinger
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
BIOLASE
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00

Avinger has a beta of 1.29, suggesting that its stock price is 29% more volatile than the S&P 500. Comparatively, BIOLASE has a beta of 0.67, suggesting that its stock price is 33% less volatile than the S&P 500.

Avinger has higher earnings, but lower revenue than BIOLASE. Avinger is trading at a lower price-to-earnings ratio than BIOLASE, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Avinger$7.65M0.21-$18.32M-$11.06-0.04
BIOLASE$48.83M0.01-$20.63M-$14.940.00

In the previous week, Avinger's average media sentiment score of 0.00 equaled BIOLASE'saverage media sentiment score.

Company Overall Sentiment
Avinger Neutral
BIOLASE Neutral

18.3% of Avinger shares are owned by institutional investors. Comparatively, 8.8% of BIOLASE shares are owned by institutional investors. 42.8% of Avinger shares are owned by insiders. Comparatively, 0.3% of BIOLASE shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

Avinger beats BIOLASE on 9 of the 14 factors compared between the two stocks.

Get BIOLASE News Delivered to You Automatically

Sign up to receive the latest news and ratings for BIOL and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BIOL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BIOL vs. The Competition

MetricBIOLASEDental equipment & supplies IndustryMedical SectorNASDAQ Exchange
Market Cap$401K$447K$5.48B$8.94B
Dividend YieldN/AN/A5.38%4.12%
P/E Ratio0.00N/A26.2119.74
Price / Sales0.010.01395.44109.12
Price / CashN/AN/A36.4957.06
Price / Book-0.170.017.935.37
Net Income-$20.63M-$40.78M$3.15B$248.34M
7 Day PerformanceN/AN/A0.75%1.67%
1 Month PerformanceN/A-12.21%3.45%4.56%
1 Year PerformanceN/AN/A34.85%18.42%

BIOLASE Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BIOL
BIOLASE
0.9962 of 5 stars
$0.01
+13.2%
$1.20
+9,900.0%
-88.9%$401K$48.83M0.00160Gap Up
AVGR
Avinger
N/A$0.47
flat
N/AN/A$1.57M$7.65M-0.0470
NUWE
Nuwellis
2.4212 of 5 stars
$0.30
+10.7%
$17.00
+5,647.1%
-95.3%$1.17M$8.74M-0.0270News Coverage
High Trading Volume
NAYA
NAYA Biosciences
N/A$1.22
-3.2%
$24.00
+1,867.2%
N/A$813K$6.23M0.0010
DYNT
Dynatronics
N/A$0.08
-11.4%
N/A-62.8%$810K$33.60M-0.09200Gap Down
CUTR
Cutera
N/A$0.04
-63.9%
$3.00
+7,592.3%
-97.4%$787K$155.21M-0.01460Gap Down
High Trading Volume
SONX
Sonendo
N/A$1.15
flat
N/AN/A$493K$44.40M-0.02250
STSS
Sharps Technology
0.3569 of 5 stars
$5.35
+2.9%
N/AN/A$280KN/A0.003
HSDT
Helius Medical Technologies
0.3295 of 5 stars
$0.32
-3.0%
N/A-98.8%$170K$520K-0.0130Stock Split
Gap Down
High Trading Volume
IONM
Assure
N/A$0.05
flat
N/A-99.6%$150K$149K0.00130Upcoming Earnings
AFIB
Acutus Medical
N/A$0.00
+13.8%
N/A-93.8%$98K$7.16M0.00340News Coverage
Gap Up

Related Companies and Tools


This page (NASDAQ:BIOL) was last updated on 7/2/2025 by MarketBeat.com Staff
From Our Partners